207 related articles for article (PubMed ID: 36716149)
1. NOVA1 acts on Impact to regulate hypothalamic function and translation in inhibitory neurons.
Tajima Y; Ito K; Yuan Y; Frank MO; Saito Y; Darnell RB
Cell Rep; 2023 Feb; 42(2):112050. PubMed ID: 36716149
[TBL] [Abstract][Full Text] [Related]
2. NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.
Saito Y; Yang Y; Saito M; Park CY; Funato K; Tabar V; Darnell RB
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2314695121. PubMed ID: 38416679
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA.
Zhang B; Sun R; Gu M; Jiang Z; Wang Y; Zhang L; Liu X; Chi Z
Biochem Cell Biol; 2024 Feb; 102(1):60-72. PubMed ID: 37816258
[TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional regulation of neuro-oncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV.
Ratti A; Fallini C; Colombrita C; Pascale A; Laforenza U; Quattrone A; Silani V
J Biol Chem; 2008 Mar; 283(12):7531-41. PubMed ID: 18218628
[TBL] [Abstract][Full Text] [Related]
5. Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis.
Krach F; Wheeler EC; Regensburger M; Boerstler T; Wend H; Vu AQ; Wang R; Reischl S; Boldt K; Batra R; Aigner S; Ravits J; Winkler J; Yeo GW; Winner B
Acta Neuropathol; 2022 Sep; 144(3):413-435. PubMed ID: 35778567
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of miR-96-5p in the mouse brain increases glutathione levels by altering NOVA1 expression.
Kinoshita C; Kikuchi-Utsumi K; Aoyama K; Suzuki R; Okamoto Y; Matsumura N; Omata D; Maruyama K; Nakaki T
Commun Biol; 2021 Feb; 4(1):182. PubMed ID: 33568779
[TBL] [Abstract][Full Text] [Related]
7. MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.
Zhi F; Wang Q; Deng D; Shao N; Wang R; Xue L; Wang S; Xia X; Yang Y
PLoS One; 2014; 9(10):e109124. PubMed ID: 25299073
[TBL] [Abstract][Full Text] [Related]
8. NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
Sayed ME; Yuan L; Robin JD; Tedone E; Batten K; Dahlson N; Wright WE; Shay JW; Ludlow AT
Oncogene; 2019 Apr; 38(16):2937-2952. PubMed ID: 30568224
[TBL] [Abstract][Full Text] [Related]
9. Dynamic expression pattern of neuro-oncological ventral antigen 1 (Nova1) in the rat brain after focal cerebral ischemia/reperfusion insults.
Li H; Sun C; Wang Y; Gao Y; Liu Y; Gao Y; Li X; Zhang C
J Histochem Cytochem; 2013 Jan; 61(1):45-54. PubMed ID: 23042482
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-138-5p protects the early diabetic retinopathy by regulating NOVA1.
Bao XY; Cao J
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7749-7756. PubMed ID: 31599400
[TBL] [Abstract][Full Text] [Related]
12. RNA binding protein Nova1 promotes tumor growth in vivo and its potential mechanism as an oncogene may due to its interaction with GABA
Zhang YA; Liu HN; Zhu JM; Zhang DY; Shen XZ; Liu TT
J Biomed Sci; 2016 Oct; 23(1):71. PubMed ID: 27733149
[TBL] [Abstract][Full Text] [Related]
13. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.
Liu XM; Li XF; Li JC
Kaohsiung J Med Sci; 2021 Apr; 37(4):286-293. PubMed ID: 33340248
[TBL] [Abstract][Full Text] [Related]
14. Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice.
Brahma MK; Xiao P; Popa M; Negueruela J; Vandenbempt V; Demine S; Cardozo AK; Gurzov EN
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145242
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia.
Hervé M; Ibrahim EC
Dis Model Mech; 2016 Aug; 9(8):899-909. PubMed ID: 27483351
[TBL] [Abstract][Full Text] [Related]
16. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
Qu L; Tian Y; Wang F; Li Z
BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
[TBL] [Abstract][Full Text] [Related]
17. A large-scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function.
Störchel PH; Thümmler J; Siegel G; Aksoy-Aksel A; Zampa F; Sumer S; Schratt G
EMBO J; 2015 Sep; 34(17):2237-54. PubMed ID: 26105073
[TBL] [Abstract][Full Text] [Related]
18. NOVA1 prevents overactivation of the unfolded protein response and facilitates chromatin access during human white adipogenesis.
Yang Z; Dong P; Cao J; Lin N; Ma S; Cao R; Cai L; Wang L; Cao C; Xue Y; Pan J; Li X; Wang K; Liu Q; Li C; Gong F; Fu X; Xiao R
Nucleic Acids Res; 2023 Jul; 51(13):6981-6998. PubMed ID: 37246706
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.
Li D; Shen M; Deng X; Bai Y
Bioengineered; 2022 Apr; 13(4):8982-8993. PubMed ID: 35348441
[TBL] [Abstract][Full Text] [Related]
20. Neuro-oncological ventral antigen 1 (NOVA1): Implications in neurological diseases and cancers.
Xin Y; Li Z; Zheng H; Ho J; Chan MTV; Wu WKK
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28394091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
